Ali-Fehmi R - Search Results

1

Correlation of tumor size with other prognostic factors in uterine serous carcinoma: a large multi-institutional study.

Winer I, Mahdi H, Bandyopadhyay S, Semaan A, Van de Vijver KK, Nucci MR, Abdul-Karim F, Hussein Y, Qureshi F, Hayek K, Alosh B, Schulz D, Cote M, Munkarah A, Morris R, Oliva E, Ali-Fehmi R. Winer I, et al. Gynecol Oncol. 2013 Feb;128(2):316-21. doi: 10.1016/j.ygyno.2012.10.027. Epub 2012 Nov 5. Gynecol Oncol. 2013. PMID: 23138135

2

The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma.

Ali-Fehmi R, Che M, Khalifeh I, Malone JM, Morris R, Lawrence WD, Munkarah AR. Ali-Fehmi R, et al. Cancer. 2003 Oct 1;98(7):1423-9. doi: 10.1002/cncr.11650. Cancer. 2003. PMID: 14508829 Free article.

3

Apoptosis, proliferation, and expression of p53 and bcl-2 in endocervical glandular intraepithelial lesions and invasive endocervical adenocarcinoma.

Ali-Fehmi R, Qureshi F, Lawrence WD, Jacques SM. Ali-Fehmi R, et al. Int J Gynecol Pathol. 2004 Jan;23(1):1-6. doi: 10.1097/01.pgp.0000102453.84429.85. Int J Gynecol Pathol. 2004. PMID: 14668542

4

Expression of Cox-2, CD34, Bcl-2, and p53 and survival in patients with primary peritoneal serous carcinoma and primary ovarian serous carcinoma.

Khalifeh I, Munkarah AR, Lonardo F, Malone JM, Morris R, Lawrence WD, Ali-Fehmi R. Khalifeh I, et al. Int J Gynecol Pathol. 2004 Apr;23(2):162-9. doi: 10.1097/00004347-200404000-00011. Int J Gynecol Pathol. 2004. PMID: 15084845

5

COX-2: a protein with an active role in gynecological cancers.

Munkarah A, Ali-Fehmi R. Munkarah A, et al. Curr Opin Obstet Gynecol. 2005 Feb;17(1):49-53. doi: 10.1097/00001703-200502000-00009. Curr Opin Obstet Gynecol. 2005. PMID: 15711411 Review.

6

Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival.

Ali-Fehmi R, Morris RT, Bandyopadhyay S, Che M, Schimp V, Malone JM Jr, Munkarah AR. Ali-Fehmi R, et al. Am J Obstet Gynecol. 2005 Mar;192(3):819-25. doi: 10.1016/j.ajog.2004.10.587. Am J Obstet Gynecol. 2005. PMID: 15746677

7

The impact of c-kit and ki-67 expression on patients prognosis in advanced ovarian serous carcinoma.

Khalifeh I, Munkarah AR, Schimp V, Morris R, Lawrence WD, Ali-Fehmi R. Khalifeh I, et al. Int J Gynecol Pathol. 2005 Jul;24(3):228-34. doi: 10.1097/01.pgp.0000164599.26969.8a. Int J Gynecol Pathol. 2005. PMID: 15968197

8

Clinical update of smooth muscle tumors of the uterus.

Solomon LA, Schimp VL, Ali-Fehmi R, Diamond MP, Munkarah AR. Solomon LA, et al. J Minim Invasive Gynecol. 2005 Sep-Oct;12(5):401-8. doi: 10.1016/j.jmig.2005.05.022. J Minim Invasive Gynecol. 2005. PMID: 16213425 Review.

9

Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays.

Chatterjee M, Mohapatra S, Ionan A, Bawa G, Ali-Fehmi R, Wang X, Nowak J, Ye B, Nahhas FA, Lu K, Witkin SS, Fishman D, Munkarah A, Morris R, Levin NK, Shirley NN, Tromp G, Abrams J, Draghici S, Tainsky MA. Chatterjee M, et al. Cancer Res. 2006 Jan 15;66(2):1181-90. doi: 10.1158/0008-5472.CAN-04-2962. Cancer Res. 2006. PMID: 16424057 Free PMC article.

10

Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer.

Solomon LA, Munkarah AR, Schimp VL, Arabi MH, Morris RT, Nassar H, Ali-Fehmi R. Solomon LA, et al. Gynecol Oncol. 2006 Jun;101(3):385-9. doi: 10.1016/j.ygyno.2005.11.049. Epub 2006 Jan 27. Gynecol Oncol. 2006. PMID: 16443262

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters